Physician profile
Timothy Michael Brand
NPI 1306108899
$13,110.52
in general payments reported to CMS, 2019-2025
28 companies · $1,739 in 2025
The $1,739 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $634 · 2021: $2,723 · 2022: $1,067 · 2023: $3,664 · 2024: $1,629 · 2025: $1,739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,218 · Travel and Lodging: $1,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,218.37 |
| Travel and Lodging | $1,813.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,728.66 | 2019-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Konect Resilia |
| Atricure, INC. | $3,508.02 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medtronic, INC. | $1,922.46 | 2021-2025 | Simulus, Avalus, Mc3 Nautilus(Tm) Ecmo Oxygenator |
| Zimmer Biomet Holdings, INC. | $644.67 | 2019-2025 | Sternalock Blu System, Ribfix Blu Advantage, A&E Medical / Sternalock Xp Rigid Fixation System |
| Abiomed | $558.86 | 2020-2025 | Impella |
| Getinge USA Sales, LLC | $507.17 | 2019-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Abbott Laboratories | $500.90 | 2021-2025 | Epic, 2nd Gen Centrimag Primary Console |
| Ethicon US, LLC | $257.12 | 2020-2025 | Prolene, Ethicon, Evarrest |
| Cvrx, INC. | $254.98 | 2022-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $222.20 | 2019-2020 | |
| Baxter Healthcare | $150.19 | 2022-2024 | Preveleak, Biosurgery - Guard, Coseal |
| Artivion, INC. | $148.64 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Amds-Ascyrus Medical |
| Angiodynamics, INC. | $99.31 | 2023-2025 | Angiovac |
| Peerless Surgical INC. | $88.43 | 2025 | |
| Stryker Corporation | $87.69 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $50.00 | 2022-2024 | Cor-Knot, Mi Knot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.19 | 2023-2025 | Lifevest |
| Livanova USA, INC. | $45.58 | 2019-2023 | Protekduo |
| Siemens Medical Solutions USA, INC. | $40.59 | 2022-2023 | Artis Pheno |
| Lemaitre Vascular, INC. | $37.18 | 2024 | Xenosure Biologic Patch, Artegraft Vascular Graft |
| Bolton Medical INC | $36.30 | 2023 | Treo Abdominal Stent-Graft System |
| Davol INC. | $33.43 | 2020 | |
| Janssen Pharmaceuticals, INC | $29.36 | 2019-2020 | |
| Convatec INC. | $25.04 | 2024 | |
| Octapharma USA, INC. | $25.03 | 2025 | Fibryga |
| Smith+Nephew, INC. | $24.47 | 2024 | Stravix |
| W. L. Gore & Associates, INC. | $22.21 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Tactile Systems Technology INC | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Brand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.